Tougher Approval Standards May Follow Vinay Prasad’s Appointment To Lead US FDA’s CBER

 
• By Sarah Karlin-Smith
  
New CBER Director Vinay Prasad may end the regulatory flexibility era at the FDA. (Shutterstock)

More from US FDA

More from Vaccines